1. Home
  2. PAR vs RAPP Comparison

PAR vs RAPP Comparison

Compare PAR & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$21.53

Market Cap

1.4B

Sector

Miscellaneous

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$25.34

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAR
RAPP
Founded
1968
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Sector
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
PAR
RAPP
Price
$21.53
$25.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$64.00
$47.00
AVG Volume (30 Days)
1.4M
349.6K
Earning Date
02-27-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$440,451,000.00
N/A
Revenue This Year
$30.39
N/A
Revenue Next Year
$11.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
39.88
N/A
52 Week Low
$22.03
$6.43
52 Week High
$72.60
$42.27

Technical Indicators

Market Signals
Indicator
PAR
RAPP
Relative Strength Index (RSI) 20.18 41.56
Support Level $27.35 $25.32
Resistance Level $40.54 $28.59
Average True Range (ATR) 1.98 1.55
MACD -1.17 -0.03
Stochastic Oscillator 0.35 14.79

Price Performance

Historical Comparison
PAR
RAPP

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: